A phase I multiple ascending dose (MAD) study of PL265

Trial Profile

A phase I multiple ascending dose (MAD) study of PL265

Planning
Phase of Trial: Phase I

Latest Information Update: 05 Jul 2017

At a glance

  • Drugs PL 265 (Primary)
  • Indications Cancer pain; Dry eyes; Neuropathic pain; Ocular pain
  • Focus Adverse reactions
  • Most Recent Events

    • 05 Jul 2017 New trial record
    • 29 Jun 2017 According to a Pharmaleads media release, data from this study is expected in 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top